Format

Send to

Choose Destination
Curr Opin Ophthalmol. 2010 Nov;21(6):468-72. doi: 10.1097/ICU.0b013e32833eab83.

Juvenile idiopathic arthritis-associated uveitis.

Author information

1
F.I. Proctor Foundation, San Francisco, California, USA.

Abstract

PURPOSE OF REVIEW:

To describe recent evidence from the literature pertaining to juvenile idiopathic arthritis (JIA)-associated uveitis.

RECENT FINDINGS:

Uveitis is most common in extended oligoarticular JIA. A significant number of patients already have ocular complications at time of diagnosis of uveitis. Risk factors for complications include either abnormally high or low intraocular pressure, posterior synechiae, male sex, temporal proximity to diagnosis of arthritis and topical corticosteroid use. Use of immunosuppressive agents significantly reduces ocular complications. Aggressive perioperative control of intraocular inflammation is necessary for successful cataract surgery with lens implantation. Controlled clinical trials are under way to assess the efficacy of biologic agents in JIA-associated uveitis. Long-term safety, however, is still unknown.

SUMMARY:

JIA-associated uveitis carries significant ocular morbidity that lasts well into adulthood. Treatment with immunosuppressive agents can reduce the risk of ocular complications. Biologic agents hold promise in the treatment of JIA-associated uveitis, but require long-term data to assess their safety.

PMID:
20729734
PMCID:
PMC3089768
DOI:
10.1097/ICU.0b013e32833eab83
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center